{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:15:00Z","timestamp":1789769700170,"version":"4.0.1"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>\n                    The use of cannabinoids in both veterinary and human medicine is controversial for legal and ethical reasons. Nonetheless, the availability and therapeutic use of naturally occurring or synthetic phytocannabinoids, such as \u0394\n                    <jats:sup>9<\/jats:sup>\n                    -tetrahydrocannabidiol and cannabidiol, have been the focus of attention in studies regarding their medical uses. This review aims to examine the role of cannabinoids in pain modulation by analyzing scientific findings regarding the signaling pathways of the endocannabinoid system and discussing the analgesic effects of synthetic cannabinoids compared to cannabinoid extracts and the extent and involvement of their receptors. In animals, studies have shown the analgesic properties of these substances and the role of the cannabinoid binding \u22121 (CB1) and cannabinoid binding \u22122 (CB2) receptors in the endocannabinoid system to modulate acute, chronic and neuropathic pain. This system consists of three main components: endogenous ligands (anandamide and 2-arachidonoylglycerol), G protein-coupled receptors and enzymes that degrade and recycle the ligands. Evidence suggests that their interaction with CB1 receptors inhibits signaling in pain pathways and causes psychoactive effects. On the other hand, CB2 receptors are associated with anti-inflammatory and analgesic reactions and effects on the immune system. Cannabis extracts and their synthetic derivatives are an effective therapeutic tool that contributes to compassionate pain care and participates in its multimodal management. However, the endocannabinoid system interacts with different endogenous ligands and neurotransmitters, thus offering other therapeutic possibilities in dogs and cats, such is the case of those patients who suffer from seizures or epilepsy, contact and atopic dermatitis, degenerative myelopathies, asthma, diabetes and glaucoma, among other inflammatory diseases. Moreover, these compounds have been shown to possess antineoplastic, appetite-stimulating, and antiemetic properties. Ultimately, the study of the endocannabinoid system, its ligands, receptors, mechanism of action, and signaling, has contributed to the development of research that shows that hemp-derived and their synthetic derivatives are an effective therapeutic alternative in the multimodal management of pain in dogs and cats due to their ability to prevent peripheral and central sensitization.\n                  <\/jats:p>","DOI":"10.3389\/fvets.2022.1050884","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:21:42Z","timestamp":1672831302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["The role of cannabinoids in pain modulation in companion animals"],"prefix":"10.3389","volume":"9","author":[{"given":"Agatha","family":"Miranda-Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mota-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Crosignani-Outeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Casas-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Mart\u00ednez-Burnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Olmos-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mora-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Verduzco-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Hern\u00e1ndez-\u00c1valos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","first-page":"612","article-title":"Medical marijuana and related legal aspects","volume":"38","author":"Marcoux","year":"2013","journal-title":"P T."},{"key":"B2","first-page":"345","article-title":"January Veterinary Medical Ethics \u2014 Cannabinoids to treat dogs and cats","volume":"60","author":"Stogdale","year":"2019","journal-title":"Can Vet J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.17221\/8762-VETMED","article-title":"The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review","volume":"61","author":"Landa","year":"2016","journal-title":"Vet Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1021\/jm400305d","article-title":"Selective cannabinoid receptor type 2. (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain","volume":"56","author":"Hollinshead","year":"2013","journal-title":"J Med Chem."},{"key":"B5","first-page":"749","article-title":"Canadian dog owners' use and perceptions of cannabis products","author":"Kogan","year":"2019","journal-title":"Can Vet J."},{"key":"B6","first-page":"27","article-title":"Chemical constituents of cannabis","volume-title":"Cannabis and Cannabinoids Pharmacology, Toxicology and Therapeutic Potential","author":"ElSohly","year":"2002"},{"key":"B7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-030-68317-7_2","article-title":"The pharmacology of cannabinoids","volume-title":"Cannabis Therapy in Veterinary Medicine. A Complete Guide","author":"Copas","year":"2021"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(00)00184-5","article-title":"historical overview of chemical research on cannabinoids","volume":"108","author":"Mechoulam","year":"2000","journal-title":"Chem Phys Lipids."},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0929-7855(96)01507-6","article-title":"Endogenous cannabinoid ligands \u2014 chemical and biological studies","volume":"14","author":"Mechoulam","year":"1996","journal-title":"J Lipid Mediat Cell Signal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1874473710902010051","article-title":"Phytocannabinoids and Endocannabinoids","volume":"2","author":"Fisar","year":"2009","journal-title":"Curr Drug Abus Rev."},{"key":"B11","first-page":"1","article-title":"Cannabinoid geometry and biological activity","volume-title":"Marijuana\/Cannabinoids: Neurobiology and Neurophysiology","author":"Mechoulam","year":"1992"},{"key":"B12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/jvp.13016","article-title":"Current review of hemp-based medicines in dogs","volume":"44","author":"Coelho","year":"2021","journal-title":"J Vet Pharmacol Ther"},{"key":"B13","first-page":"1","volume-title":"Understanding Marijuana: A New Look at the Scientific Evidence","author":"Earleywine","year":"2002"},{"key":"B14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","article-title":"The cannabinoid receptors","volume":"68","author":"Howlett","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B15","first-page":"149","article-title":"Chemistry, metabolism, and toxicology of cannabis: clinical implications","volume":"7","author":"Sharma","year":"2012","journal-title":"Iran J Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","article-title":"Pharmacological actions of cannabinoids","volume":"168","author":"Pertwee","year":"2005","journal-title":"Handb Exp Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences","volume":"152","author":"McPartland","year":"2007","journal-title":"Br J Pharmacol."},{"key":"B18","first-page":"14","article-title":"Pharmacology of cannabinoids","volume":"25","author":"Grotenhermen","year":"2005","journal-title":"Neuro Endocrinol Lett"},{"key":"B19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphar.2017.00422","article-title":"An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol","volume":"8","author":"Morales","year":"2017","journal-title":"Front Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol Disord - Drug Targets."},{"key":"B21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1476-5381.2012.02223.x","article-title":"New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2","volume":"168","author":"Kenakin","year":"2013","journal-title":"Br J Pharmacol."},{"key":"B22","first-page":"10","article-title":"Cannabinoids and the endocannabinoids system","volume":"1","author":"Grotenhermen","year":"2006","journal-title":"Cannabinoids."},{"key":"B23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/ani9100832","article-title":"Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats","volume":"9","author":"Deabold","year":"2019","journal-title":"Animals."},{"key":"B24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.rvsc.2021.08.001","article-title":"Cannabidiol-based natural health products for companion animals: recent advances in the management of anxiety, pain, and inflammation","volume":"140","author":"Yu","year":"2021","journal-title":"Res Vet Sci."},{"key":"B25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-030-68317-7_13","article-title":"Product selection and dosing considerations","volume-title":"Cannabis therapy in veterinary medicine. A complete guide","author":"Silver","year":"2021"},{"key":"B26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3238\/arztebl.2012.0495","article-title":"The therapeutic potential of cannabis and cannabinoids","volume":"3","author":"Grotenhermen","year":"2012","journal-title":"Dtsch Aerzteblatt Online"},{"key":"B27","first-page":"27","article-title":"Analysis of synthetic cannabinoids in botanical material: a review of analytical methods and findings","volume":"25","author":"Presley","year":"2013","journal-title":"Forensic Sci Revsion."},{"key":"B28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J Anal Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fvets.2018.00165","article-title":"Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs","volume":"5","author":"Gamble","year":"2018","journal-title":"Front Vet Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fvets.2020.00505","article-title":"Pharmacokinetics of cannabidiol, cannabidiolic acid, \u03b49-tetrahydrocannabinol, tetrahydrocannabinolic acid and related metabolites in canine serum after dosing with three oral forms of hemp extract","volume":"7","author":"Wakshlag","year":"2020","journal-title":"Front Vet Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jvp.12896","article-title":"Serum cannabidiol, tetrahydrocannabinol. (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles","volume":"43","author":"Hannon","year":"2020","journal-title":"J Vet Pharmacol Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1177\/1098612X211004215","article-title":"Safety and tolerability of escalating cannabinoid doses in healthy cats","volume":"23","author":"Kulpa","year":"2021","journal-title":"J Feline Med Surg."},{"key":"B34","first-page":"469","article-title":"Pharmacokinetics of cannabidiol in dogs","volume":"16","author":"Samara","year":"1988","journal-title":"Drug Metab Dispos."},{"key":"B35","first-page":"178","article-title":"Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs","volume":"82","author":"Bartner","year":"2018","journal-title":"Can J Vet Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/biom10020279","article-title":"Pharmacokinetics of sativex\u00ae in dogs: towards a potential cannabinoid-based therapy for canine disorders","volume":"10","author":"Fern\u00e1ndez-Trapero","year":"2020","journal-title":"Biomolecules."},{"key":"B37","doi-asserted-by":"publisher","first-page":"34041","DOI":"10.3389\/fvets.2020.583404","article-title":"Pharmacokinetic and Safety evaluation of various oral doses of a novel 1:20 THC:CBD cannabis herbal extract in dogs","volume":"7","author":"Chicoine","year":"2020","journal-title":"Front Vet Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/ani9090686","article-title":"The endocannabinoid system of animals","volume":"9","author":"Silver","year":"2019","journal-title":"Animals."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: Physiology and pharmacology","volume":"40","author":"Rodr\u00edguez de Fonseca","year":"2005","journal-title":"Alcohol Alcohol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","article-title":"Cannabinoids and pain: sites and mechanisms of action","volume":"45","author":"Starowicz","year":"2017","journal-title":"Adv Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1517\/13543784.2014.918603","article-title":"Cannabinoids in pain management: CB1, CB2, and non-classic receptor ligands","volume":"23","author":"Davis","year":"2014","journal-title":"Expert Opin Investig Drugs."},{"key":"B43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.physiol.010908.163149","article-title":"Endocannabinoid signaling and long-term synaptic plasticity","volume":"71","author":"Heifets","year":"2009","journal-title":"Annu Rev Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB 2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc Natl Acad Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1517\/14728222.2013.754426","article-title":"Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases","volume":"17","author":"Vasileiou","year":"2013","journal-title":"Expert Opin Ther Targets."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/138955709787001785","article-title":"Cannabinoid Type 2 Receptor as a target for chronic - pain","volume":"9","author":"Beltramo","year":"2009","journal-title":"Mini-Reviews Med Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2. (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures \u2014 A short review","volume":"90","author":"Svizenska","year":"2008","journal-title":"Pharmacol Biochem Behav."},{"key":"B48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0006-8993(98)01321-3","article-title":"Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord","volume":"822","author":"Hohmann","year":"1999","journal-title":"Brain Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","article-title":"The effects of cannabinoids on the brain","volume":"58","author":"Ameri","year":"1999","journal-title":"Prog Neurobiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.2174\/1570159X14666160729155441","article-title":"Advances in the physiology of GPR55 in the central nervous system","volume":"15","author":"Marichal-Cancino","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur J Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00418-018-1684-7","article-title":"Localization of cannabinoid receptors CB1, CB2, GPR55, and PPAR\u03b1 in the canine gastrointestinal tract","volume":"150","author":"Galiazzo","year":"2018","journal-title":"Histochem Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00418-020-01854-0","article-title":"Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract","volume":"153","author":"Stanzani","year":"2020","journal-title":"Histochem Cell Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/187153008785700118","article-title":"Cannabinoids as therapeutic agents for ablating neuroinflammatory disease","volume":"8","author":"Cabral","year":"2008","journal-title":"Endocrine Metab Immune Disord Targets."},{"key":"B55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation","volume":"141","author":"Walter","year":"2004","journal-title":"Br J Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","article-title":"Cannabinoids: reward, dependence, and underlying neurochemical mechanisms?","volume":"169","author":"Tanda","year":"2003","journal-title":"Psychopharmacology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1124\/jpet.102.045575","article-title":"Antinociceptive synergy between \u03b4 9 -tetrahydrocannabinol and opioids after oral administration","volume":"304","author":"Cichewicz","year":"2003","journal-title":"J Pharmacol Exp Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coph.2004.08.012","article-title":"Opioids: cellular mechanisms of tolerance and physical dependence","volume":"5","author":"Bailey","year":"2005","journal-title":"Curr Opin Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/156800705774322111","article-title":"Cannabinoids","volume":"4","author":"Grotenhermen","year":"2005","journal-title":"Curr Drug Target -CNS Neurol Disord."},{"key":"B60","first-page":"450","article-title":"2022 WSAVA guidelines for the recognition, assessment and treatment of pain","volume":"35","author":"Monteiro","year":"2022","journal-title":"J Small Anim Pract"},{"key":"B61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejphar.2007.04.010","article-title":"Synergy between \u03949-tetrahydrocannabinol and morphine in the arthritic rat","volume":"567","author":"Cox","year":"2007","journal-title":"Eur J Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12917-017-1245-7","article-title":"Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study","volume":"13","author":"Valastro","year":"2017","journal-title":"BMC Vet Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ani10091505","article-title":"Oral transmucosal cannabidiol oil formulation as part of a multimodal analgesic regimen: effects on pain relief and quality of life improvement in dogs affected by spontaneous osteoarthritis","volume":"10","author":"Brioschi","year":"2020","journal-title":"Animals."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1097\/j.pain.0000000000001896","article-title":"randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain","volume":"161","author":"Verrico","year":"2020","journal-title":"Pain."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","article-title":"Synergistic interactions between cannabinoid and opioid analgesics","volume":"74","author":"Cichewicz","year":"2004","journal-title":"Life Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/bs.mie.2017.05.003","article-title":"Techniques for the cellular and subcellular localization of endocannabinoid receptors and enzymes in the mammalian brain","volume":"63","author":"Cristino","year":"2017","journal-title":"Methods Enzymologic"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e0181064","DOI":"10.1371\/journal.pone.0181064","article-title":"Spatial distribution of cannabinoid receptor type 1. (CB1) in normal canine central and peripheral nervous system","volume":"12","author":"Freundt-Revilla","year":"2017","journal-title":"PLoS ONE."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/0024-3205(95)00195-C","article-title":"An examination of the central sites of action of cannabinoid-induced antinociception in the rat","volume":"56","author":"Martin","year":"1995","journal-title":"Life Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience."},{"key":"B71","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience."},{"key":"B72","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.bjp.0707440","article-title":"Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate","volume":"152","author":"Rea","year":"2007","journal-title":"Br J Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1006\/mcne.2000.0844","article-title":"Cannabinoid CB1 receptor expression in rat spinal cord","volume":"15","author":"Farquhar-Smith","year":"2000","journal-title":"Mol Cell Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1746-6148-9-262","article-title":"Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder","volume":"9","author":"Gesell","year":"2013","journal-title":"BMC Vet Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jclinane.2019.03.011","article-title":"Perioperative care of cannabis users: a comprehensive review of pharmacological and anesthetic considerations","volume":"57","author":"Echeverria-Villalobos","year":"2019","journal-title":"J Clin Anesth."},{"key":"B76","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur J Biochem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2017.08.053","article-title":"Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus","volume":"363","author":"Li","year":"2017","journal-title":"Neuroscience."},{"key":"B79","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/vde.12658","article-title":"Cannabinoid receptor types 1 and 2 and peroxisome proliferator-activated receptor-\u03b1: distribution in the skin of clinically healthy cats and cats with hypersensitivity dermatitis","volume":"29","author":"Miragliotta","year":"2018","journal-title":"Vet Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/sj.bjp.0707568","article-title":"In vitro and in vivo characterization of A-796260: a selective cannabinoid CB 2 receptor agonist exhibiting analgesic activity in rodent pain models","volume":"153","author":"Yao","year":"2008","journal-title":"Br J Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000087656","article-title":"Spinal and supraspinal contributions to central sensitization in peripheral neuropathy","volume":"14","author":"Suzuki","year":"2005","journal-title":"Neurosignals."},{"key":"B82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/SPC.0000000000000055","article-title":"Descending pain modulation and chronification of pain","volume":"8","author":"Ossipov","year":"2014","journal-title":"Curr Opin Support Palliat Care."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1152\/jn.01037.2002","article-title":"Endocannabinoids mediate rapid retrograde signaling at interneuron \u2192 pyramidal neuron synapses of the neocortex","volume":"89","author":"Trettel","year":"2003","journal-title":"J Neurophysiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejphar.2005.10.020","article-title":"Cannabinoid CB2 receptor agonist activity in the hindpaw incision","volume":"527","author":"LaBuda","year":"2005","journal-title":"Eur J Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1523\/JNEUROSCI.23-03-01026.2003","article-title":"Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats","volume":"23","author":"Milligan","year":"2003","journal-title":"J Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/fcp.12008","article-title":"The role of endocannabinoids in pain modulation","volume":"27","author":"Zogopoulos","year":"2013","journal-title":"Fundam Clin Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1124\/pr.110.003491","article-title":"The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications","volume":"63","author":"Miller","year":"2011","journal-title":"Pharmacol Rev."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1073\/pnas.0409888102","article-title":"CB 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids","volume":"102","author":"Ibrahim","year":"2005","journal-title":"Proc Natl Acad Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","article-title":"Cannabinoids and pain: new insights from old molecules","volume":"9","author":"Vu\u010dkovi\u0107","year":"2018","journal-title":"Front Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.3390\/ijms21228870","article-title":"Cannabidiol for pain treatment: [0mm][4mm]focus on pharmacology and mechanism of action","volume":"21","author":"Mlost","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B91","first-page":"1","article-title":"The use of cannabidiol-rich hemp oil extract to treat canine osteoarthritis- related pain: a pilot study","volume":"58","author":"Kogan","year":"2020","journal-title":"J Am Anim Hosital Assoc."},{"key":"B92","volume-title":"Cannabis de Uso Medicinal para el Tratamiento de Dolor Cr\u00f3nico de un Labrador Retriever con Osteoartrosis","author":"Furtado de \u00c1lava","year":"2019"},{"key":"B93","first-page":"35","article-title":"Sarcoma cancer treatment using extracted cannabis oil in cat","volume":"3","author":"Buranakarn","year":"2020","journal-title":"Int J Sci Innov Technol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5326\/JAAHA-MS-7119","article-title":"Evaluation of the effect of cannabidiol on naturally occurring osteoarthritis-associated pain: a pilot study in dogs","volume":"57","author":"Mejia","year":"2021","journal-title":"J Am Anim Hosp Assoc."},{"key":"B95","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fphar.2017.00391","article-title":"Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats","volume":"8","author":"Genaro","year":"2017","journal-title":"Front Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis","volume":"20","author":"Hammell","year":"2016","journal-title":"Eur J Pain."},{"key":"B97","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fvets.2020.00051","article-title":"Preliminary investigation of the safety of escalating cannabinoid doses in healthy dogs","volume":"7","author":"Vaughn","year":"2020","journal-title":"Front Vet Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2460\/ajvr.82.5.405","article-title":"Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs","volume":"82","author":"Vaughn","year":"2021","journal-title":"Am J Vet Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13028-018-0398-0","article-title":"Marijuana intoxication in a cat","volume":"60","author":"Janeczek","year":"2018","journal-title":"Acta Vet Scand."},{"key":"B100","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.tcam.2009.10.008","article-title":"Oncology pain in veterinary patients","volume":"25","author":"Looney","year":"2010","journal-title":"Top Companion Anim Med."},{"key":"B101","first-page":"4269","article-title":"Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance","volume":"25","author":"Queiroga","year":"","journal-title":"Anticancer Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","article-title":"An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD Oromucosal Spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics","volume":"46","author":"Johnson","year":"2013","journal-title":"J Pain Symptom Manage."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e0255591","DOI":"10.1371\/journal.pone.0255591","article-title":"Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells","volume":"16","author":"Inkol","year":"2021","journal-title":"PLoS ONE."},{"key":"B104","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.rvsc.2022.09.013","article-title":"Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours","volume":"152","author":"Rinaldi","year":"2022","journal-title":"Res Vet Sci."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.892306","article-title":"A case report of subcutaneously injected liposomal cannabidiol formulation used as a compassion therapy for pain management in a dog","author":"Shilo-Benjamini","year":"2022","journal-title":"Front Vet Sci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0091-3057(01)00531-7","article-title":"Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew","volume":"69","author":"Darmani","year":"2001","journal-title":"Pharmacol Biochem Behav."},{"key":"B107","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5055\/jom.2009.0034","article-title":"The analgesic potential of cannabinoids","volume":"5","author":"Elikottil","year":"2009","journal-title":"J Opioid Manag."},{"key":"B108","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.vaa.2020.04.017","article-title":"The effect of cannabidiol on sevoflurane minimum alveolar concentration reduction produced by morphine in rats","volume":"48","author":"Orden","year":"2021","journal-title":"Vet Anaesth Analg."},{"key":"B109","first-page":"162","article-title":"Effects of cannabis extract premedication on anesthetic depth","volume":"157","author":"Ibera","year":"2018","journal-title":"Harefuah."},{"key":"B110","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jpain.2017.12.002","article-title":"The involvement of the endocannabinoid system in the peripheral antinociceptive action of ketamine","volume":"19","author":"Ferreira","year":"2018","journal-title":"J Pain."},{"key":"B111","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/09712119.2010.9707109","article-title":"Cannabis Indica. (Bhang) extract as preanaesthetic to propofol anaesthesia in dogs","volume":"37","author":"Kumar","year":"2010","journal-title":"J Appl Anim Res."},{"key":"B112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-030-68317-7_5","article-title":"Cannabinoids for pain management","volume-title":"Cannabis Therapy in Vterinary Medicine. A complete Guide. Cham","author":"Mosley","year":"2021"},{"key":"B113","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2460\/ajvr.73.7.988","article-title":"Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis","volume":"73","author":"Campora","year":"2012","journal-title":"Am J Vet Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.3389\/fvets.2021.645667","article-title":"Feeding cannabidiol. (CBD)-containing treats did not affect canine daily voluntary activity","volume":"8","author":"Morris","year":"2021","journal-title":"Front Vet Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"437S","DOI":"10.1002\/j.1552-4604.1981.tb02624.x","article-title":"The cannabinoids as potential antiepileptics","volume":"21","author":"Karler","year":"1981","journal-title":"J Clin Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2460\/javma.254.11","article-title":"Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy","volume":"254","author":"McGrath","year":"2019","journal-title":"J Am Vet Med Assoc."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.1050884\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:21:56Z","timestamp":1672831316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.1050884\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":116,"alternative-id":["10.3389\/fvets.2022.1050884"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.1050884","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1050884"}}